Serotonin and dopamine antagonism in obsessive-compulsive disorder: Effect of atypical antipsychotic drugs

Pharmacopsychiatry

Volumn 33, Issue 6, 2000, Pages 236-238

  Ramasubbu, R ^a   Ravindran, A ^a   Lapierre, Y ^a  

^a ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; FLUVOXAMINE; HALOPERIDOL; LITHIUM CARBONATE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PIMOZIDE; RISPERIDONE; SEROTONIN 2 RECEPTOR; SEROTONIN ANTAGONIST; VALPROATE SEMISODIUM;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CASE REPORT; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MEGADOSE; FEMALE; HAIR LOSS; HUMAN; MALE; OBSESSION; PRIORITY JOURNAL; SYMPTOM;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOMIPRAMINE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PIRENZEPINE; RISPERIDONE; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0033676353     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8360     Document Type: Article

References (21)

1. Dopamine blocking activity of clomipramine in patients with obsessive compulsive disorder
2. Emergence of obsessive compulsive symptoms during treatment with clozapine
3. Radioreceptor binding profile of the atypical antipsychotic olanzepine
4. Treatment of refractory OCD with the Dopamine agonist Bromocriptine
5. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive compulsive disoder
6. Efficacy of fluvoxamine in obsessive compulsive disorder: A double blind comparison with placebo
7. The Yale-Brown obsessive compulsive scale: Development, use, and reliability
8. Specificity of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder: Comparison of fluvoxamine and desipramine
9. Clomipramine, clonazepam and clonidine treatment of obsessive-compulsive disorder
10. Successful treatment of obsessive-compulsive disorder with clonidine hydrochloride
11. Risperidone, serotonergic mechanisms and obsessive compulsive symptoms in schizophrenia
12. 2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study
13. A new framework for investigating antipsychotic action in humans: Lessons from PET imaging
14. 2 receptor occupancy of olanzepine in schizophrenia: A PET investigation
15. 2 receptors
16. Neuroleptic addition in fluvoxamine-refractory obsessive compulsive disorder: An open case series
17. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics
18. Risperidone and obsessive compulsive symptoms
19. Risperidone augmentation of SRI treatment for refractory obsessive compulsive disorder
20. Occupancy of central neurotransmitter receptor by risperidone, clozapine and haloperidol measured in vivo by quantitative autoradiography
21. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial